Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA)

CUSIP: 152309100

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Ordinary shares, nominal value 0.002 GBP per share
Shares outstanding
145,993,531
Total 13F shares
74,395,267
Share change
+3,114,648
Total reported value
$840,663,455
Put/Call ratio
28%
Price per share
$11.30
Number of holders
69
Value change
+$66,659,727
Number of buys
45
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 152309100?
CUSIP 152309100 identifies CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) as of Q1 2024

As of 31 Mar 2024, Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,395,267 shares. The largest 10 holders included Medicxi Ventures Management (Jersey) Ltd, GENERAL ATLANTIC, L.P., EcoR1 Capital, LLC, Vida Ventures Advisors, LLC, PERCEPTIVE ADVISORS LLC, First Light Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Point72 Asset Management, L.P., and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 69 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.